4281 - 4290 of 9131 Results
Title
Year
-
OPENTitle: OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: A pilot randomized clinical trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 174End Page: 178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.009Best OA location URL: https://zenodo.org/record/3832127Citation Count: 22
-
OPENTitle: Alzheimer's disease alters oligodendrocytic glycolytic and ketolytic gene expressionJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 9Start Page: 1474End Page: 1486Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12310Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12310Citation Count: 64
- Movement disorders: discoveries in pathophysiology and therapy2014RESTRICTEDTitle: Movement disorders: discoveries in pathophysiology and therapyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 14Issue #: 1Start Page: 9End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(14)70307-2Citation Count: 3
- MicroRNA profiling and the role of microRNA-132 in neurodegeneration using a rat model2013RESTRICTEDTitle: MicroRNA profiling and the role of microRNA-132 in neurodegeneration using a rat modelJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 553Issue #:Start Page: 153End Page: 158Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2013.08.001Citation Count: 66
- Association of Neurological Family Health History in Parkinson's Diseases2024RESTRICTEDTitle: Association of Neurological Family Health History in Parkinson's DiseasesJournal Name: 2024 International Conference on Brain Computer Interface & Healthcare Technologies (iCon-BCIHT)Publisher: IEEEVol:Issue #:Start Page: 207End Page: 212Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/icon-bciht63907.2024.10882367Citation Count: 1
- Exploring the neuroprotective potential of immunosuppressants in Parkinson's disease2025RESTRICTEDTitle: Exploring the neuroprotective potential of immunosuppressants in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 132Issue #:Start Page: 107294End Page: 107294Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107294Citation Count: 2
- Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer’s and Parkinson’s disease models of neurodegeneration2018RESTRICTEDTitle: Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer’s and Parkinson’s disease models of neurodegenerationJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page: 4176End Page: 4193Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddy308Citation Count: 33
-
OPENTitle: Awake Testing during Deep Brain Stimulation Surgery Predicts Postoperative Stimulation Side Effect ThresholdsJournal Name: Brain SciencesPublisher: MDPI AGVol: 9Issue #: 2Start Page: 44End Page: 44Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci9020044Best OA location URL: https://www.mdpi.com/2076-3425/9/2/44/pdf?version=1550479268Citation Count: 15
-
OPENTitle: Genetic Architecture of Parkinson's Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson's Disease ResearchJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page: 524End Page: 524Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00524Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00524/pdfCitation Count: 50
-
OPENTitle: Ade novocompound targeting α-synuclein improves deficits in models of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 139Issue #: 12Start Page: 3217End Page: 3236Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/aww238Best OA location URL: https://academic.oup.com/brain/article-pdf/139/12/3217/24173157/aww238.pdfCitation Count: 156